Catalyst Wire Dossier Catalyst Wire Dossier

SR604

· Equilibra Bioscience LLC
Drug timelines are a Plus or Pro feature.

1 regulatory and trial event tracked for SR604, covering 2026-03-10 to 2026-03-10. Get the full timeline:

Most recent: Clinical Trial Update: A Study of Safety, Tolerability, Pharmacokinetics, and Pharmacodynamics of SR604 in Two Participants Groups (Part A: Healthy Participants, and Part B: Participants With Hemophilia A or Hemophilia B or Factor VII Deficiency) [Phase 1]

See pricing